6550--INTENT TO SOLE SOURCE - Buffalo VA Thermo Fisher GENEXUS Reagents
Inactive on SAM.gov — responses were due 27 Aug 2026 · Unrestricted (full and open) · Department of Veterans Affairs (VA) · NAICS 325413 · Solicitation 36C24226Q0938
Following NAICS 325413? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 27 August 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs on behalf of the Buffalo VA Medical Center intends to award a Firm Fixed Price (FFP), sole source action to Large Businesses (LB). Name of Contractor: Thermo Fisher Scientific Street Address: 5781 Van Allen Way City, State, Zip: Carlsbad, CA 92008 USA The Pathology and Laboratory Medicine Department requires reagents and supplies outlined in this procurement to continue to perform patient testing on the Thermo Fisher Genexus instrument, and Genexus Purification System. Both instruments are owned and operated by the Buffalo VAMC Pathology and Laboratory Medicine department. The Genexus instrument utilizes the Oncomine Precision Assay which enables simultaneous detection of biomarkers across 50 genes, including key targets within EGFR, BRAF, KRAS, ALK, ROS1, NTRK, RET, HER2, and others, from solid tissue samples. Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The OPA NGS panel has significant clinical utility in cancer treatment by providing comprehensive genomic profiling of a tumor sample, allowing healthcare providers to identify actionable genetic alterations and select the most appropriate targeted therapies for a patient based on their specific tumor mutations, leading to more effective treatment plans. Item number Description Quantity A40261 Ion Torrent Genexus Barcodes 1-32- AS HD 12 A40266 Ion Torrent Genexus Pipette tips 7 4483354 96-well plates (20/box) 4 A40269 Ion Torrent GX5 Chip and Genexus Coupler 6 A40271 Genexus Sequencing Kit 6 AB0626 Adhesive Foil Seals Microp Lates oe PCR Plates 1 A40263 Genexus Templating Strips 3 and 4-GX5 (8/BOX) 7 A45539 Genexus FFPE DNA/RNA Purification Kit 6 A46291 Oncomine Precision Assay GX 12 This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 13.105(a). The Department of Veterans Affairs, Buffalo, NY location intends to issue a sole source award contract to Thermo Fisher Scientific, all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored. NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on August 27, 2025. Responses to be submitted to Morgan Weeks, Contracting Officer at Morgan.Weeks1@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Gove
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
